Actelion enters into an agreement to acquire privately-held Ceptaris Therapeutics

By WebmasterJuly 31, 2013November 1st, 2024No Comments

Actelion enters into an agreement to acquire privately-held Ceptaris Therapeutics
Read more here

Previous PostCeptaris Receives FDA Approval for VALCHLOR(TM) (mechlorethamine) Gel
Next PostIntezyne Technologies Expands Its Oncology Pipeline Through Strategic Acquisition of Niiki Pharma